Market Closed -
Nyse
04:00:02 2024-05-24 pm EDT
|
5-day change
|
1st Jan Change
|
32.66
USD
|
+3.19%
|
|
+7.93%
|
+21.10%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
11,703
|
9,723
|
12,335
|
5,198
|
4,576
|
5,553
|
-
|
-
|
Enterprise Value (EV)
1 |
18,070
|
16,405
|
18,960
|
11,653
|
10,525
|
12,768
|
12,768
|
12,768
|
P/E ratio
|
13.5
x
|
19.7
x
|
9.19
x
|
-2.36
x
|
-5.48
x
|
6.01
x
|
4.67
x
|
4.18
x
|
Yield
|
2.56%
|
3.22%
|
2.51%
|
5.86%
|
6.67%
|
5.51%
|
5.6%
|
5.73%
|
Capitalization / Revenue
|
0.65
x
|
0.54
x
|
0.63
x
|
0.28
x
|
0.29
x
|
0.3
x
|
0.29
x
|
0.27
x
|
EV / Revenue
|
1
x
|
0.9
x
|
0.97
x
|
0.62
x
|
0.66
x
|
0.69
x
|
0.67
x
|
0.63
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
23.2
x
|
21.3
x
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
4.31%
|
4.7%
|
-
|
Price to Book
|
0.59
x
|
0.43
x
|
0.6
x
|
1.67
x
|
0.77
x
|
0.78
x
|
0.69
x
|
0.59
x
|
Nbr of stocks (in thousands)
|
198,331
|
193,265
|
180,709
|
169,215
|
169,662
|
170,027
|
-
|
-
|
Reference price
2 |
59.01
|
50.31
|
68.26
|
30.72
|
26.97
|
32.66
|
32.66
|
32.66
|
Announcement Date
|
2/5/20
|
2/3/21
|
2/2/22
|
2/8/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,046
|
18,162
|
19,639
|
18,665
|
16,027
|
18,513
|
19,197
|
20,195
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,861
|
1,218
|
2,094
|
-991
|
1,367
|
1,724
|
2,123
|
2,228
|
Operating Margin
|
10.31%
|
6.71%
|
10.66%
|
-5.31%
|
8.53%
|
9.31%
|
11.06%
|
11.03%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-1,148
|
1,300
|
1,554
|
1,700
|
Net income
1 |
886
|
499
|
1,405
|
-2,240
|
-835
|
1,534
|
1,299
|
1,398
|
Net margin
|
4.91%
|
2.75%
|
7.15%
|
-12%
|
-5.21%
|
8.29%
|
6.77%
|
6.92%
|
EPS
2 |
4.380
|
2.560
|
7.430
|
-13.02
|
-4.920
|
5.439
|
6.989
|
7.815
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-
|
550
|
600
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
2.97%
|
3.13%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
35.84%
|
46.18%
|
-
|
Dividend per Share
2 |
1.510
|
1.620
|
1.710
|
1.800
|
1.800
|
1.800
|
1.828
|
1.870
|
Announcement Date
|
2/5/20
|
2/3/21
|
2/2/22
|
2/8/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,769
|
4,718
|
4,641
|
4,630
|
4,676
|
4,657
|
4,730
|
4,673
|
1,967
|
4,584
|
4,598
|
4,640
|
4,672
|
4,771
|
4,800
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
386
|
399
|
531
|
-2,172
|
250
|
393
|
511.6
|
131
|
357
|
196
|
492
|
493
|
538
|
-
|
-
|
Operating Margin
|
8.09%
|
8.46%
|
11.44%
|
-46.91%
|
5.35%
|
8.44%
|
10.82%
|
2.8%
|
18.15%
|
4.28%
|
10.7%
|
10.63%
|
11.52%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
237
|
92
|
269
|
-3,137
|
-35
|
-1,170
|
602
|
1,034
|
-1,613
|
1,528
|
361
|
380.5
|
368
|
346
|
386
|
Net income
1 |
220
|
103
|
231
|
-2,575
|
1
|
-909
|
502
|
819
|
-1,246
|
1,191
|
302
|
294.5
|
311.8
|
265.5
|
323.5
|
Net margin
|
4.61%
|
2.18%
|
4.98%
|
-55.62%
|
0.02%
|
-19.52%
|
10.61%
|
17.53%
|
-63.35%
|
25.98%
|
6.57%
|
6.35%
|
6.67%
|
5.56%
|
6.74%
|
EPS
2 |
1.200
|
0.5800
|
1.340
|
-15.17
|
0.0100
|
-5.350
|
2.940
|
4.790
|
-7.350
|
6.930
|
1.685
|
1.617
|
1.769
|
1.400
|
1.839
|
Dividend per Share
2 |
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
0.4500
|
Announcement Date
|
2/2/22
|
5/4/22
|
8/3/22
|
11/2/22
|
2/8/23
|
5/9/23
|
8/2/23
|
11/1/23
|
2/8/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
6,367
|
6,682
|
6,625
|
6,455
|
5,949
|
7,215
|
7,215
|
7,215
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-
|
550
|
600
|
-
|
ROE (net income / shareholders' equity)
|
9.7%
|
6.3%
|
11%
|
-6.9%
|
8.9%
|
9.26%
|
10.8%
|
10.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
100.0
|
118.0
|
114.0
|
18.40
|
34.80
|
41.70
|
47.60
|
55.40
|
Cash Flow per Share
|
-
|
2.750
|
0.8000
|
23.40
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/5/20
|
2/3/21
|
2/2/22
|
2/8/23
|
2/8/24
|
-
|
-
|
-
|
Last Close Price
32.66
USD Average target price
30.3
USD Spread / Average Target -7.23% Consensus |
1st Jan change
|
Capi.
|
---|
| +21.10% | 5.55B | | +13.94% | 80.24B | | +9.69% | 51.58B | | +6.29% | 49.83B | | +24.01% | 47.73B | | +15.09% | 42.86B | | +22.38% | 39.39B | | +1.50% | 29.67B | | -2.71% | 29.14B | | -13.68% | 26.75B |
Other Life & Health Insurance
|